candidiasis
CANDIDIASIS
Candida sp are the most common cause of fungal infections.
 It can cause infections that range from benign mucocutaneous illnesses to invasive process that may affect any organ.
 It is considered as normal flora in the gastrointestinal and genitourinary tracts, but when there is an imbalance in the ecological niche, they can invade and cause disease.
Most common risk factors include broad-spectrum antibiotic use, central venous catheter use, receipt of parenteral nutrition, receipt of renal placement therapy by patients in ICUs, neutropenia, implantable prosthetic device use and receipt of immunosuppressive agents.

Candidiasis Drug Information

Drug Information

Indication: Invasive candidiasis including candidemia in adults.

Indication: Invasive aspergillosis; fluconazole-resistant serious invasive Candida infections (eg, C krusei); serious...

Indication: Dermatophytes or yeasts, mycoses & other fungi eg, Tinea capitis, corporis, manuum, barbae, cruris, pedis....

Indication: Oropharyngeal cavity & GIT candidosis in adults & ped ≥6 mth.

Endix
econazole nitrate + triamcinolone acetonide

Indication: Dermatophytosis: Tinea pedis, tinea corporis, tinea capitis, tinea cruris, tinea barbae. Tinea versicolor, can...

Indication: Invasive candidiasis in childn & adults. Oesophageal candidiasis in adults, adolescents ≥16 yr & el...

Indication: Topical treatment of dermatophyte skin infections eg, tinea corporis, cruris, manus & pedis due to Trichop...

Indication: Invasive aspergillosis in patients w/ disease refractory to amphotericin B or intolerant to these drugs. Fusar...

Pevisone
econazole nitrate + triamcinolone acetonide

Indication: Dermatomycoses complicated by inflammatory &/or pruritic manifestations of skin disorders.

1  /  11
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago
Diagnosis of heart diseases has abruptly and significantly decreased across the globe due to the coronavirus disease 2019 (COVID-19) pandemic, especially affecting poorer countries, reveals a study.
Pearl Toh, -21 hours ago
While it is well known that COVID-19 illness is associated with coagulopathy, the optimal anticoagulation strategy remains elusive, and two studies presented at the ASH 2020 Congress further add to the growing debate on the appropriate anticoagulant dose for hospitalized patients with COVID-19.